RxDoctor Payments Data

Peter Pluscht, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Mobile, ALNPI 1639177470

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,855 of the $3,812 with a category attached, or 74.9%. Abbott accounts for 82.5% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $1,659, 4.1 times the $407 reported in 2019. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in AL, where the typical reported total is $5,387.

$3,812in general payments, 2019–2025

Across 49 payments — averaging $77.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Edwards Lifesciences$278
  • Abiomed$140
  • Chiesi USA, Inc.$82
  • Atricure, Inc.$55
  • Medtronic$33
  • plus $79 from 4 others

What the payments were for

  • Travel & lodging$95725%
  • Food & beverage$2,85575%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,812 in reported general payments places this provider in the 35th percentile of 68 thoracic surgery (cardiothoracic vascular surgery) providers in Alabama.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Alabama

Medicare billing

Part B allowed, 2024
$372,553
Medicare patients
253
Services billed
587

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban58$33,402
EntrestoSacubitril/Valsartan22$13,754
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen132$906
Amiodarone Hcl52$528
Atorvastatin Calcium54$389
Metoprolol Succinate70$365
Potassium Chloride58$323
Losartan Potassium34$185
ClopidogrelClopidogrel Bisulfate31$123
Furosemide67$110
Carvedilol28$97
Tramadol Hcl25$77
Spironolactone16$44
Metoprolol Tartrate15$33
Amlodipine Besylate12$25

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →